People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellibre, Inc. | — | Biotechnology | Series A | $20.8M | $31.2M | 2019 |
| Perfect Herbal Blends, Inc. | — | Other | Seed | $1.4M | $1.5M | 2022 |
Benjamin Chiarelli at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Benjamin Chiarelli on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Doug Hannah | 1 | 2 |
| Nicky Caiazza | 1 | 1 |
| Scott Zingheim | 1 | 1 |
| Spiros Kambourakis | 1 | 1 |
| Douglas J. Hannah | 1 | 1 |
| Benjamin J. Chiarelli | 1 | 1 |
| Dean Hollander | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.